TRx 0237

TRx 0237, also called LMT-X or Methylene Blue, is a second-generation tau protein aggregation inhibitor currently in development for the treatment of Alzheimer’s disease (AD) and frontotemporal dementia.

Price Not Available Please inquire TRx 0237 Supplier Page

Catalog Number	613-11-6
Alternative Name(s)	TRx 0237; TRx0237; TRx-0237; 3-N,3-N,7-N,7-N-tetramethyl-10H-phenothiazine-3,7-diamine; leucomethylene blue; leukomethylene blue; Panatone; 613-11-6; N,N,N',N'-Tetramethyl-10H-phenothiazine-3,7-diamine; N3,N3,N7,N7-tetramethyl-10H-phenothiazine-3,7-diamine; leucoform; Reduced methylene blue
Molecular Formula	C17H21N3S1
CAS#	613-11-6
Inchi	1S/C16H19N3S/c1-18(2)11-5-7-13-15(9-11)20-16-10-12(19(3)4)6-8-14(16)17-13/h5-10,17H,1-4H3
Inchi Key	QTWZICCBKBYHDM-UHFFFAOYSA-N
Size	Please inquire
Supplier Page	https://www.bocsci.com/trx-0237-cas-613-11-6-item-129376.html